People · Operator
Named in public records as an officer, director or promoter · active 2012–2023 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NeuMoDx Molecular, Inc. | — | Other Health Care | Series B | $54.8M | $444.0M | 2012 |
| Gregor Diagnostics, Inc. | — | Biotechnology | Series A | $14.5M | $678K | 2023 |
Sundaresh Brahmasandra at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sundaresh Brahmasandra on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeffrey Williams | 1 | 10 |
| Jan Garfinkle | 1 | 7 |
| Edward Michael | 1 | 6 |
| William Burkoth | 1 | 5 |
| Nicole Walker | 1 | 4 |
| Steven Weinstein | 1 | 4 |
| Michael Partsch | 1 | 4 |
| Gilbert G Garcia | 1 | 1 |
| Mike G Bress | 1 | 1 |
| Lauren Tyra | 1 | 1 |
| Tobias Zutz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.